S&P 500

5.479,19

0,02%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Cyclo Therapeutics Inc (CYTH)
Cyclo Therapeutics Inc (CYTH) Notícias

CYTH

Cyclo Therapeutics (CYTH)

Cyclo Therapeutics Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:CYTH

1 2 3 4 5 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
25/06/2024	10:25	Business Wire	Cyclo Therapeutics to Present at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium 2024	NASDAQ:CYTH	Cyclo Therapeutics Inc
14/06/2024	17:01	GlobeNewswire Inc.	Rafael Holdings Reports Third Quarter Fiscal 2024 Financial Results	NASDAQ:CYTH	Cyclo Therapeutics Inc
30/05/2024	10:00	Business Wire	Cyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC™ Trial of Niemann-Pick Type C1	NASDAQ:CYTH	Cyclo Therapeutics Inc
16/05/2024	09:05	Business Wire	Cyclo Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:CYTH	Cyclo Therapeutics Inc
18/03/2024	10:05	Business Wire	Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update	NASDAQ:CYTH	Cyclo Therapeutics Inc
14/03/2024	10:34	Business Wire	Cyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol® Cyclo™ for the Treatment of Alzheimer’s Disease	NASDAQ:CYTH	Cyclo Therapeutics Inc
13/03/2024	18:04	GlobeNewswire Inc.	Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results	NASDAQ:CYTH	Cyclo Therapeutics Inc
04/03/2024	18:33	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:CYTH	Cyclo Therapeutics Inc
15/02/2024	18:46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CYTH	Cyclo Therapeutics Inc
14/02/2024	16:44	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:CYTH	Cyclo Therapeutics Inc
29/01/2024	11:15	Business Wire	Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer’s Disease from the U.S. Patent and Trademark Office	NASDAQ:CYTH	Cyclo Therapeutics Inc
22/01/2024	08:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CYTH	Cyclo Therapeutics Inc
28/12/2023	23:48	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:CYTH	Cyclo Therapeutics Inc
27/12/2023	18:15	Business Wire	Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc.	NASDAQ:CYTH	Cyclo Therapeutics Inc
18/12/2023	11:15	Business Wire	Cyclo Therapeutics Announces Positive Outcome from Type C Meeting with the U.S. FDA Discussing Trappsol® Cyclo™ Clinical Program for the Treatment of Niemann-Pick Disease Type C1	NASDAQ:CYTH	Cyclo Therapeutics Inc
18/12/2023	08:02	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:CYTH	Cyclo Therapeutics Inc
14/12/2023	18:01	GlobeNewswire Inc.	Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results	NASDAQ:CYTH	Cyclo Therapeutics Inc
22/11/2023	02:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:CYTH	Cyclo Therapeutics Inc
21/11/2023	11:15	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:CYTH	Cyclo Therapeutics Inc
21/11/2023	10:05	Business Wire	Cyclo Therapeutics to Present at the 20th Annual WORLDSymposium™ 2024	NASDAQ:CYTH	Cyclo Therapeutics Inc
20/11/2023	10:50	Edgar (US Regulatory)	Form S-4/A - Registration of securities, business combinations: [Amend]	NASDAQ:CYTH	Cyclo Therapeutics Inc
15/11/2023	10:05	Business Wire	Cyclo Therapeutics Reports Third Quarter 2023 Financial Results	NASDAQ:CYTH	Cyclo Therapeutics Inc
14/11/2023	16:41	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CYTH	Cyclo Therapeutics Inc
07/11/2023	18:45	Edgar (US Regulatory)	Form S-4 - Registration of securities, business combinations	NASDAQ:CYTH	Cyclo Therapeutics Inc
30/10/2023	17:01	GlobeNewswire Inc.	Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results	NASDAQ:CYTH	Cyclo Therapeutics Inc
24/10/2023	17:43	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:CYTH	Cyclo Therapeutics Inc
23/10/2023	09:05	Business Wire	Cyclo Therapeutics Announces Early Exercise of Warrants by Board Members, Management and a Significant Shareholder Resulting in Cash Proceeds of $2.4 Million	NASDAQ:CYTH	Cyclo Therapeutics Inc
05/10/2023	09:05	Business Wire	Cyclo Therapeutics to Present at 8th Annual Dawson James Conference	NASDAQ:CYTH	Cyclo Therapeutics Inc
21/09/2023	10:35	GlobeNewswire Inc.	Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference	NASDAQ:CYTH	Cyclo Therapeutics Inc
21/09/2023	09:05	Business Wire	Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement	NASDAQ:CYTH	Cyclo Therapeutics Inc